drugset / Trial / NCT01097265

Study of Micrometastases in Patients With Stage I or Stage II Localized Colon Cancer That Can Be Removed by Surgery

NCT01097265

Phase 2/3 Unknown 1500 enrolled Jeroen Bosch Hospital
RandomizedOpen-labelDiagnostic

Summary

RATIONALE: Diagnostic procedures such as sentinel lymph node mapping may help doctors find patients who are at risk of developing micrometastases and plan better treatment. PURPOSE: This randomized phase II/III trial is studying micrometastases in patients with stage I or stage II localized colon cancer that can be removed by surgery.

Timeline

Start
2010-07
Primary completion
2015-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Capecitabine Small molecule Oral
Subject Oxaliplatin Small molecule Intravenous

Indications